Estimating the Long-Term Outcomes Associated With Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations


In this article, Huang et al introduce a comprehensive list of models for extrapolating overall survival data and illustrate their application to a clinical trial data set. They also compare and contrast the model outcomes and provide insights on the tradeoffs in model selection in the context of the probable underlying biomedical processes for immuno-oncology treatments.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now